# PDS Biotechnology Discusses PDS-0301 for Metastatic Colorectal Cancer

> PDS Biotechnology Corporation details PDS-0301 immunocytokine's role in treating metastatic colorectal cancer.
- Title: PDS Biotechnology Discusses PDS-0301 for Metastatic…
- Summary: PDS Biotechnology Corporation details PDS-0301 immunocytokine's role in treating metastatic colorectal cancer. PDS Biotechnology Corporation discussed…
- Keywords: pds biotechnology, pds-0301, immunocytokine, metastatic colorectal cancer, nasdaq, pdsb, money, business, PDS, Biotechnology, Discusses, Metastatic
- Source: Seekingalpha — https://seekingalpha.com/article/4955005-pds-biotechnology-corporation-pdsb-discusses-pdsminus-0301-immunocytokine-and-its-role-in
- Author: SA Transcripts
- Published: 2026-10-17T23:04:51+00:00
- Read time: 1 min
- Topics: pds biotechnology, pds-0301, immunocytokine, metastatic colorectal cancer, nasdaq, pdsb, money, business
## PDS Biotechnology Corporation
PDS Biotechnology Corporation published a slide deck discussing PDS-0301 immunocytokine's role in treating metastatic colorectal cancer.
## Slide Deck Published
The slide deck was created by PDS Biotechnology Corporation in conjunction with this event.
## Transcripts Team
Seeking Alpha's transcripts team is responsible for developing quarterly earnings calls and expanding coverage.
## Key takeaway

PDS Biotechnology Corporation discussed PDS-0301 immunocytokine's potential for metastatic colorectal cancer treatment.